[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635008":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":24,"responsibleParty":41,"collaborators":10,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":56,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":64,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"First Affiliated Hospital of Fujian Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"CKM Registry Cohort",null,"Adults aged 18 to 80 years receiving inpatient care at the First Affiliated Hospital of Fujian Medical University with cardiovascular disease, kidney disease, metabolic disease, or key examination and laboratory data supporting CKM phenotyping, enrolled for structured data collection and longitudinal follow-up.",[13],{"name":14,"affiliation":5,"role":15},"Dajun Chai","PRINCIPAL_INVESTIGATOR",[17,21],{"name":14,"role":18,"phone":19,"phoneExt":10,"email":20},"CONTACT","008659187981637","dajunchai-fy@fjmu.edu.cn",{"name":22,"role":18,"phone":10,"phoneExt":10,"email":23},"Hailin Zhang","824224843@qq.com",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"The First Affiliated Hospital of Fujian Medical University","RECRUITING","Fuzhou","Fujian","350011","China","CN",{"type":34,"coordinates":35},"Point",[36,37],119.30611,26.06139,{"lat":37,"lon":36},[40],{"name":22,"role":18,"phone":19,"phoneExt":10,"email":23},{"type":15,"investigatorFullName":14,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Professor and Chief Physician, Department of Cardiology","100635008","study-on-construction-of-whole-lifecycle-cohort-big-data-management-and-clinical-prognosis-of-cardio-renal-metabolic-ckm-syndrome-100635008",false,"NCT07547098","Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome","CKM-LCBP","Inclusion Criteria:\n\n* Age 18 years or older.\n* Inpatient record available at the First Affiliated Hospital of Fujian Medical University with retrievable identifiers for data linkage.\n* Cardiovascular disease, kidney disease, metabolic disease, or key examination\u002Flaboratory information supporting CKM phenotyping.\n* Willingness to participate and provision of written informed consent.\n* Ability to complete baseline assessment and follow-up.\n* Full civil capacity and ability to understand study information.\n\nExclusion Criteria:\n\n* Refusal to provide written informed consent.\n* Severe psychiatric disease or cognitive impairment precluding participation.\n* End-stage disease with expected survival less than 1 year.\n* Long-term absence more than 6 months preventing reliable follow-up.\n* Participation in another clinical study that may interfere with endpoint adjudication.\n* Missing key fields preventing linkage of examinations, imaging, and outcomes.","ALL","18 Years","80 Years",{"count":54,"type":55},8000,"ESTIMATED","5 Years","OBSERVATIONAL","This is a single-center observational registry study aiming to establish a structured clinical and multimodal imaging database for cardiovascular-kidney-metabolic (CKM) populations and to support lifecycle follow-up and outcome management. Adult patients aged 18-80 years with cardiovascular, kidney, and\u002For metabolic diseases or key data for CKM phenotyping will be enrolled at the First Affiliated Hospital of Fujian Medical University. The study integrates retrospective data entry and prospective follow-up, including clinical records, laboratory tests, medications, electrocardiography, echocardiography, vascular function assessment, carotid and abdominal ultrasound, bone density, coronary CTA and post-processing data. The primary outcome is the first occurrence of a cardiorenal composite endpoint. Participants will be followed for up to 5 years through active annual follow-up and passive monthly data updates to support risk stratification, real-world evidence generation, and CKM management pathway optimization.",[60,61,62,63],"Cardiovascular Diseases (CVD)","Chronic Kidney Disease","Metabolic Diseases","Cardiovascular-kidney-metabolic Syndrome",[65,66,67,68],"CKM syndrome","Cardiovascular-Kidney-Metabolic","Patient registry","Real-world data","2026-04-19",{"date":71,"type":72},"2026-04-23","ACTUAL",{"date":74,"type":72},"2026-03-01",{"date":76,"type":55},"2031-02-28",{"name":5,"class":6},1]